معرفی
Dr. Deepa Purushothaman is a Research Fellow in the Department of Psychiatry at Yale School of Medicine, serving as the Early Detection and Assessment Coordinator (EDAC) for DMHAS Region 5 within the Specialized Treatment for Early Psychosis (STEP) program. She holds an MD in Psychiatry and a Postdoctoral Fellowship in Schizophrenia from NIMHANS, Bangalore. Her clinical focus is on general adult psychiatry, with expertise in schizophrenia spectrum disorders. Her research explores social cognitive deficits in schizophrenia, early psychosis detection, and the neurobiology of mental illness, alongside interests in the history of psychiatry and integrative therapies like yoga and Ayurveda.
Education:
- Postdoctoral Fellowship in Schizophrenia, National Institute of Mental Health and Neurosciences (NIMHANS), 2020
- MD in Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), 2019
Research Interests: Her work spans social cognition deficits in schizophrenia, early psychosis intervention strategies, and the application of yoga and Ayurveda in mental healthcare. She has published extensively on topics such as tele-yoga efficacy, integrative treatment guidelines for schizophrenia, and the neurobiological underpinnings of delusions.
Recent Contributions: Her 2025 study on fNIRS-based social disconnect analysis in psychosis and 2024 meta-analysis on yoga therapy for schizophrenia cognition highlight her focus on innovative diagnostic tools and complementary interventions. She co-developed culturally adapted counseling modules using ancient Indian texts and contributed to global treatment guidelines (INTEGRATE).
Awards:
- Young Investigator Award from Schizophrenia Research Foundation (2018)
Advisory & Collaborations: She leads the STEP program's early detection efforts and collaborates with interdisciplinary teams on projects like the 'Integrative Approach for Managing Tardive Dyskinesia.' Her lab engages in translational research bridging neuroimaging, epigenetics, and clinical outcomes.
Labs/Teams: Active in the STEP program and associated with the Whisk Cup Streamline initiative, focusing on early psychosis intervention and integrative care models.